Research ArticleCancer

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma

See allHide authors and affiliations

Science Translational Medicine  14 Nov 2018:
Vol. 10, Issue 467, eaat5933
DOI: 10.1126/scitranslmed.aat5933
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article